Information Links
Guidelines - Respiratory system
Quick-reference summaries of key national treatment guidance for respiratory diseases including asthma and COPD.
MIMS summaries
At-a-glance summaries of authoritative evidence-based clinical guidelines for respiratory diseases commonly encountered in primary care, prepared by the MIMS editorial team.
Assessing Fitness to Fly (CAA Guidance)
Key advice from the Civil Aviation Authority (CAA)...
Management of Asthma in Adults (BTS/SIGN Guideline)
Summary of BTS/SIGN asthma protocol in adults.
Management of Asthma in Children (BTS/SIGN Guideline)
Summary of BTS/SIGN asthma protocol in children.
Management of Asthma - Inhaled Corticosteroid Doses (BTS/SIGN Guideline)
Categorisation of inhaled corticosteroid doses in asthma.
Management of COPD (NICE Guideline)
Summary of NICE guidance on COPD treatment.
NICE technology appraisals
Decisions by the National Institute for Health and Care Excellence on NHS access to treatments for respiratory diseases.
-
Mepolizumab for Treating Severe Refractory Eosinophilic Asthma (TA431)
-
Lumacaftor-Ivacaftor for Treating Cystic Fibrosis Homozygous for the F508del Mutation (TA398)
-
Ceritinib for Previously Treated Anaplastic Lymphoma Kinase Positive Non-Small-Cell Lung Cancer (TA395)
-
Nintedanib for Treating Idiopathic Pulmonary Fibrosis (TA379)
-
Pirfenidone for Treating Idiopathic Pulmonary Fibrosis (TA282)
-
Omalizumab for Treating Severe Persistent Allergic Asthma (TA278)
-
Mannitol Dry Powder for Inhalation for Treating Cystic Fibrosis (TA266)
-
Roflumilast for the Management of Severe Chronic Obstructive Pulmonary Disease (TA244)
-
Asthma, Chronic: Use of Inhaled Corticosteroids in Adults and Children >12 Years (NICE)
-
Asthma, Chronic: Use of Inhaled Corticosteroids in Children <12 Years (NICE)
MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.